MOZOM-analyse
HPV vaccination: almost zero mortality, but coverage is becoming a weak spot
- Source
- The Guardian
- MOZOM headline
- HPV vaccination: almost zero mortality, but coverage is becoming a weak spot
- Original headline
- HPV jabs cut risk of dying from cervical cancer before 30 to almost zero
- Author
- MOZOM-redactie
- Date
- 24 juni 2026 om 03:28
- Subject
- According to The Guardian, a Lancet study points to very strong protection provided by HPV vaccination, while declining vaccination rates raise new risks.
Summary of the original report
Based on research in The Lancet, The Guardian reports that girls who receive HPV vaccination early in adolescence have virtually no risk of dying from cervical cancer before the age of thirty. The study links the British vaccination program to almost two hundred deaths prevented. At the same time, researchers warn that declining vaccination rates, especially after the pandemic and in urban areas, could undermine progress. The health file thus shifts from breakthrough to reach.
Striking in this message
The tension between almost zero risk and avoidable return is striking. This combination makes prevention difficult: success can actually make the urgency less visible.
Less visible context
What remains less visible is that vaccination programs depend on everyday logistics, school contact, reminders and equal access, not just on medical evidence.
Possible message behind the news
A possible message is that cancer prevention is not finished when the vaccine exists. It must be reorganized every year.
Neutral conclusion
The HPV numbers are strongly positive. The vulnerability now mainly lies in reach, trust and the prevention of a proven success from slowly crumbling.